| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.005 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.005 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.007 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.009 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.009 |